Immunogenicity of meningococcal polysaccharide conjugate vaccine as a replacement for meningococcal polysaccharide vaccine in children in Guangzhou, China

被引：2
作者：
He, Qing [1 ]
Xiao, Jiali [2 ]
Liu, Meizhen [3 ]
Li, Zhencui [3 ]
Xu, Jiangxiong [1 ]
Zhang, Zhoubin [1 ]
机构：
[1] Guangzhou Ctr Dis Control & Prevent, Guangzhou 510440, Peoples R China
[2] Guangzhou Tianhe Ctr Dis Control & Prevent, Guangzhou 510655, Peoples R China
[3] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 511430, Peoples R China
来源：
VACCINE | 2022年 / 40卷 / 09期
关键词：
vaccine; Meningococcal polysaccharide vaccine; Immunogenicity; Persistence; Meningococcal polysaccharide conjugate vaccine; PREVENTION; DISEASE;
D O I：
10.1016/j.vaccine.2021.09.021
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
To assess the durability of antibody persistence after substitution of the MPCV vaccine for the MPSV-A vaccine in children, an observational study was conducted in children who voluntarily received two doses of MPCV-AC instead of MPSV-A between March 2017 and March 2018 in Guangzhou, China. In total, 131 and 47 participants were enrolled in the 3-year-old and 6-year-old groups, respectively. In the 3-year-old group, the seroprotection rate and GMT values for Men A and Men C were raised significantly after 1 month post-dose 1 MPSV booster vaccination. All immune indicators were significantly lower in pre dose 1 MPSV booster vaccination in the 3-year-old group than after pre-dose 2 MPSV booster vaccination in the 6-year-old group. While no significant differences were found in most immune indicators between the 1-month post-dose 1 MPSV booster vaccination in the 3-year-old group and pre-dose 2 MPSV booster vaccination in 6-year-old group. The substitute meningococcal immunization schedule showed a good immunogenicity in young children, and good sequential immunogenicity with MPSV booster immunization. (c) 2021 Published by Elsevier Ltd.
引用
收藏
页码：1370 / 1375
页数：6
相关论文
共 50 条
[31]   ost-effectiveness of meningococcal polysaccharide serogroups A, C, W-135 and Y conjugate vaccine in Australian adolescents [J].
Si, Si ;
Zomer, Ella ;
Fletcher, Samantha ;
Lee, Jenny ;
Liew, Danny .
VACCINE, 2019, 37 (35) :5009-5015
[32]   Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study [J].
Zhu, Feng-Cai ;
Hu, Yue-Mei ;
Li, Ya-Nan ;
Shu, Jean-Denis ;
Oster, Philipp .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) :919-926
[33]   Carrier-mediated enhancement of cognate T cell help:: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine [J].
Pérez-Melgosa, M ;
Ochs, HD ;
Linsley, PS ;
Laman, JD ;
van Meurs, M ;
Flavell, RA ;
Ernst, RK ;
Miller, SI ;
Wilson, CB .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2001, 31 (08) :2373-2381
[34]   Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naive and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study [J].
van der Vliet, D. ;
Vesikari, T. ;
Sandner, B. ;
Martinon-Torres, F. ;
Muzsay, G. ;
Forsten, A. ;
Adelt, T. ;
Diaz Gonzalez, C. ;
Simko, R. ;
B'Chir, S. ;
Neveu, D. ;
Jordanov, E. ;
Dhingra, M. S. .
EPIDEMIOLOGY AND INFECTION, 2021, 149
[35]   Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharicle vaccine in two- to ten-year-old children [J].
Pichichero, M ;
Casey, J ;
Blatter, M ;
Rothstein, E ;
Ryall, R ;
Bybel, M ;
Gilmet, G ;
Papa, T .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (01) :57-62
[36]   Pneumococcal polysaccharide conjugate vaccine [J].
不详 .
AUSTRALIAN PRESCRIBER, 2010, 33 (02) :56-57
[37]   High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine [J].
O'Connor, Daniel ;
Clutterbuck, Elizabeth A. ;
Thompson, Amber J. ;
Snape, Matthew D. ;
Ramasamy, Maheshi N. ;
Kelly, Dominic F. ;
Pollard, Andrew J. .
GENOME MEDICINE, 2017, 9
[38]   Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa [J].
Pajon, Rolando ;
Fergus, Andrew M. ;
Granoff, Dan M. .
PLOS ONE, 2013, 8 (06)
[39]   Long-term thermal stability of group C meningococcal polysaccharide-tetanus toxoid conjugate vaccine [J].
Lee, Shwu-Maan ;
Petermann, Robert ;
Porte, Quallyna ;
Berezuk, Greg ;
Crowe, Brian ;
Shirtz, John .
HUMAN VACCINES, 2007, 3 (01) :27-32
[40]   Immunogenicity of A 23-Valent Pneumococcal Polysaccharide Vaccine Among Mexican Children [J].
Elva Espinosa-Padilla, Sara ;
Murata, Chiharu ;
Estrada-Parra, Sergio ;
Santos-Argumedo, Leopoldo ;
Mascarenas, Cesar ;
Franco-Paredes, Carlos ;
Javier Espinosa-Rosales, Francisco .
ARCHIVES OF MEDICAL RESEARCH, 2012, 43 (05) :402-405
12345